Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × ALT-803 × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Cyclophosphamide 36 fludarabine 28 Rituximab 25 obinutuzumab 10 fludarabine phosphate 9 Bendamustine Hydrochloride 9 pembrolizumab 7 Vincristine 6 Specimen Handling 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 Etoposide 6 venetoclax 5 ibrutinib 5 Inotuzumab Ozogamicin 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 glofitamab 4 Interleukin-2 4 polatuzumab vedotin 3 Radiation 3 Nivolumab 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Gemcitabine 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07049432 2026-01-23

CARMEN-803

University of Utah

Phase 1 Not yet recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡